Zonghua Luo

1.4k total citations
38 papers, 1.2k citations indexed

About

Zonghua Luo is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Zonghua Luo has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 10 papers in Pharmacology and 8 papers in Physiology. Recurrent topics in Zonghua Luo's work include Sphingolipid Metabolism and Signaling (13 papers), Cholinesterase and Neurodegenerative Diseases (10 papers) and Computational Drug Discovery Methods (6 papers). Zonghua Luo is often cited by papers focused on Sphingolipid Metabolism and Signaling (13 papers), Cholinesterase and Neurodegenerative Diseases (10 papers) and Computational Drug Discovery Methods (6 papers). Zonghua Luo collaborates with scholars based in United States and China. Zonghua Luo's co-authors include Ling Huang, Chuan‐Jun Lu, Xingshu Li, Xingshu Li, Jun Yan, Hai‐Bin Luo, Yang Sun, Tao Su, Fei Mao and Wenjun Shan and has published in prestigious journals such as Journal of Medicinal Chemistry, Dalton Transactions and European Journal of Medicinal Chemistry.

In The Last Decade

Zonghua Luo

38 papers receiving 1.2k citations

Peers

Countries citing papers authored by Zonghua Luo

Since Specialization

Citations

This map shows the geographic impact of Zonghua Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zonghua Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zonghua Luo more than expected).

Fields of papers citing papers by Zonghua Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zonghua Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zonghua Luo. The network helps show where Zonghua Luo may publish in the future.

Co-authorship network of co-authors of Zonghua Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Zonghua Luo. A scholar is included among the top collaborators of Zonghua Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zonghua Luo. Zonghua Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis and evaluation of highly selective quinazoline-2,4-dione ligands for sphingosine-1-phosphate receptor 2 2022 ·RSC Medicinal Chemistry ·Zonghua Luo, Hui Liu, Yanbo Yu, Robert J. Gropler, Robyn S. Klein, Zhude Tu	3
2	The impact of dopamine D2-like agonist/antagonist on [18F]VAT PET measurement of VAChT in the brain of nonhuman primates 2019 ·European Journal of Pharmaceutical Sciences ·Hui Liu, Zonghua Luo, Jiwei Gu, Yi Su, Hubert Flores, Stanley M. Parsons, Yun Zhou, Joel S. Perlmutter, Zhude Tu	4
3	Development of a carbon-11 PET radiotracer for imaging TRPC5 in the brain 2019 ·Organic & Biomolecular Chemistry ·Yanbo Yu, Qianwa Liang, Hui Liu, Zonghua Luo, Hongzhen Hu, Joel S. Perlmutter, Zhude Tu	10
4	Automated production of a sphingosine-1 phosphate receptor 1 (S1P1) PET radiopharmaceutical [11C]CS1P1 for human use 2019 ·Applied Radiation and Isotopes ·Zonghua Luo, Jiwei Gu, (unknown), (unknown), Joel S. Perlmutter, Delphine L. Chen, Tammie L.S. Benzinger, Zhude Tu	8
5	Design, synthesis, and in vitro bioactivity evaluation of fluorine-containing analogues for sphingosine-1-phosphate 2 receptor 2019 ·Bioorganic & Medicinal Chemistry ·Zonghua Luo, Hui Liu, Robyn S. Klein, Zhude Tu	10
6	Radiosynthesis and evaluation of a fluorine-18 labeled radioligand targeting vesicular acetylcholine transporter 2018 ·Bioorganic & Medicinal Chemistry Letters ·Xuyi Yue, Zonghua Luo, Hui Liu, (unknown), Stanley M. Parsons, Joel S. Perlmutter, Zhude Tu	1
7	In Vivo Characterization of Two ¹⁸F-Labeled PDE10A PET Radioligands in Nonhuman Primate Brains 2018 ·ACS Chemical Neuroscience ·Hui Liu, Hongjun Jin, Zonghua Luo, Xuyi Yue, Xiang Zhang, Hubert Flores, (unknown), Joel S. Perlmutter, Zhude Tu	5
8	Syntheses andin vitrobiological evaluation of S1PR1 ligands and PET studies of four F-18 labeled radiotracers in the brain of nonhuman primates 2018 ·Organic & Biomolecular Chemistry ·Zonghua Luo, Junbin Han, Hui Liu, Adam J. Rosenberg, Delphine L. Chen, Robert J. Gropler, Joel S. Perlmutter, Zhude Tu	14
9	Syntheses and in vitro evaluation of new S1PR1 compounds and initial evaluation of a lead F-18 radiotracer in rodents 2018 ·European Journal of Medicinal Chemistry ·Zonghua Luo, Adam J. Rosenberg, Hui Liu, Junbin Han, Zhude Tu	19
10	Design, synthesis, and in vitro evaluation of quinolinyl analogues for α-synuclein aggregation 2018 ·Bioorganic & Medicinal Chemistry Letters ·Xuyi Yue, Dhruva D. Dhavale, Junfeng Li, Zonghua Luo, Jialu Liu, Hao Yang, Robert H. Mach, Paul T. Kotzbauer, (unknown)	17
11	Cholinergic imbalance in lumbar spinal cord of a rat model of multiple sclerosis 2018 ·Journal of Neuroimmunology ·Chunling Liu, Hui Liu, Hongjun Jin, Xuyi Yue, Zonghua Luo, Zhude Tu	1
12	Design and synthesis of pyrazolopyridine derivatives as sphingosine 1-phosphate receptor 2 ligands 2017 ·Bioorganic & Medicinal Chemistry Letters ·Zonghua Luo, Xuyi Yue, Hao Yang, Hui Liu, Robyn S. Klein, Zhude Tu	12
13	Synthesis, resolution, and in vitro evaluation of three vesicular acetylcholine transporter ligands and evaluation of the lead fluorine-18 radioligand in a nonhuman primate 2017 ·Organic & Biomolecular Chemistry ·Xuyi Yue, Hongjun Jin, Hui Liu, Zonghua Luo, Xiang Zhang, (unknown), Hubert Flores, Joel S. Perlmutter, Stanley M. Parsons, Zhude Tu	7
14	Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer’s disease 2014 ·Bioorganic & Medicinal Chemistry ·Zonghua Luo, Liang Liang, Jianfei Sheng, Yanqing Pang, Jianheng Li, Ling Huang, Xingshu Li	53
15	Novel tacrine–ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity 2013 ·Bioorganic & Medicinal Chemistry Letters ·Fei Mao, Jianwen Chen, Qi Zhou, Zonghua Luo, Ling Huang, Xingshu Li	53
16	Inhibition of cholinesterase activity and amyloid aggregation by berberine-phenyl-benzoheterocyclic and tacrine-phenyl-benzoheterocyclic hybrids 2012 ·Bioorganic & Medicinal Chemistry ·Ling Huang, Tao Su, Wenjun Shan, Zonghua Luo, Yang Sun, Feng He, Xingshu Li	71
17	O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: Multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-β aggregation 2012 ·Bioorganic & Medicinal Chemistry ·Fei Mao, Ling Huang, Zonghua Luo, Anqiu Liu, Chuan‐Jun Lu, Zhi Xie, Xingshu Li	55
18	Benzenediol-berberine hybrids: Multifunctional agents for Alzheimer’s disease 2011 ·Bioorganic & Medicinal Chemistry ·Huailei Jiang, Xu Wang, Ling Huang, Zonghua Luo, Tao Su, Ke Ding, Xingshu Li	75
19	Berberine derivatives, with substituted amino groups linked at the 9-position, as inhibitors of acetylcholinesterase/butyrylcholinesterase 2010 ·Bioorganic & Medicinal Chemistry Letters ·Ling Huang, Zonghua Luo, Feng He, (unknown), (unknown), Xingshu Li	37
20	Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase 2010 ·Bioorganic & Medicinal Chemistry ·Ling Huang, Zonghua Luo, Feng He, (unknown), Xingshu Li	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact